phenyl acetate has been researched along with Coronary Artery Disease in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (66.67) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berbeć, H; Cybulski, M; Daniluk, J; Stążka, J; Wysocka, A; Wysokiński, A; Zapolski, T | 1 |
| Chambers, HW; Chambers, JE; Dail, MB; McDaniel, CY; Wills, RW | 1 |
| Corsini, A; Ferri, N | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Carvalho, AB; Cuppari, L; Dalboni, MA; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Muenz, LR; Qunibi, W | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Cuppari, L; Dalboni, MA; de Carvalho, AB; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Karakas, M; Koenig, W | 1 |
| Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Charytan, D; Di Carli, MF; Dorbala, S; Ganz, P; McMahon, GT; Schelbert, HR | 1 |
| Anderson, T; Blue, JW; Grégoire, J; Heinonen, T; Imus, J; L'Allier, PL; Lambert, J; Lespérance, J; Rodés, J; Tardif, JC | 1 |
| MUNE, N | 1 |
| Paret, CL | 1 |
| Alfonso, F; Anderson, TJ; Bertrand, O; Blue, J; Grégoire, J; Hassan, A; Heinonen, T; Ibrahim, R; L'Allier, PL; Lespérance, J; McLain, R; Pressler, ML; Reeves, F; Rodés-Cabau, J; Schampaert, E; Tardif, JC; Title, LM | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Cohen, E; Grégoire, J; Guertin, MC; Heinonen, T; Ibrahim, R; Keller, PF; L'Allier, PL; Lavoie, MA; LeMay, M; Levesque, S; Tardif, JC | 1 |
| Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
| Moliterno, DJ | 1 |
| Dennis, VW; Fatica, RA | 1 |
2 review(s) available for phenyl acetate and Coronary Artery Disease
| Article | Year |
|---|---|
[Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk].
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Acute Coronary Syndrome; Atherosclerosis; Benzaldehydes; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Humans; Indoles; Keto Acids; Lipoproteins; Oximes; Phospholipase A2 Inhibitors; Phospholipases A | 2014 |
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
8 trial(s) available for phenyl acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Topics: Acetates; Bone Remodeling; Brazil; Calcinosis; Calcium Compounds; Chelating Agents; Comorbidity; Coronary Artery Disease; Female; Humans; Incidence; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
Coronary circulatory function in patients with the metabolic syndrome.
Topics: Acetamides; Acetates; Adenosine; Adolescent; Adult; Aged; Anticholesteremic Agents; Body Mass Index; C-Reactive Protein; Cholesterol; Cohort Studies; Coronary Artery Disease; Coronary Circulation; Data Interpretation, Statistical; Double-Blind Method; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Positron-Emission Tomography; Risk Factors; Sulfonamides; Sulfonic Acids; Vascular Resistance; Vasodilator Agents; Young Adult | 2011 |
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
Topics: Acetamides; Acetates; Adult; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Research Design; Statistics as Topic; Sulfonamides; Sulfonic Acids; Ultrasonography | 2002 |
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Topics: Acetamides; Acetates; Aged; Apolipoproteins B; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Image Processing, Computer-Assisted; Male; Middle Aged; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Sulfonamides; Sulfonic Acids; Treatment Failure; Ultrasonography, Interventional | 2004 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee.
Topics: Acetates; Adult; Aged; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Rate; Tyrosine | 2000 |
11 other study(ies) available for phenyl acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.
Topics: Acetates; Adult; Aged; Aryldialkylphosphatase; Biomarkers; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paraoxon; Phenols; Postoperative Complications; Risk Factors; Substrate Specificity; Time Factors; Treatment Outcome | 2017 |
Paraoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibility.
Topics: Acetates; Aged; Aryldialkylphosphatase; Black or African American; Coronary Artery Disease; Coumarins; Female; Genetic Association Studies; Genetic Markers; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mississippi; Organophosphorus Compounds; Paraoxon; Phenols; Polymorphism, Single Nucleotide; White People | 2014 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
Topics: Acetates; Adult; Bone Remodeling; Calcinosis; Calcium Compounds; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery disease.
Topics: Acetates; Animals; Clinical Trials, Phase II as Topic; Coronary Artery Disease; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Keto Acids; Patents as Topic; Phospholipases A2, Secretory; Prodrugs | 2009 |
[Betasyamine in therapy of coronary arteriosclerosis].
Topics: Acetates; Arteriosclerosis; Coronary Artery Disease; Glycine | 1954 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Topics: Acetamides; Acetates; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Regression Analysis; Sulfonamides; Sulfonic Acids; Total Lung Capacity; Ultrasonography, Interventional | 2006 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |